Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HDAC Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00719875
What this trial is testing

HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Yale University 24
Testing effectiveness (Phase 2)Looking for participantsNCT04512534
What this trial is testing

Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Fudan University 51
Testing effectiveness (Phase 2)UnknownNCT04994210
What this trial is testing

Sintilimab in Combination With Chidamide in Newly Diagnosed ENKTCL

Who this might be right for
Safety and Efficacy
Sun Yat-sen University 30
Testing effectiveness (Phase 2)UnknownNCT00866762
What this trial is testing

The Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia

Who this might be right for
Polycythemia VeraEssential Thrombocythemia
Copenhagen University Hospital at Herlev 60
Testing effectiveness (Phase 2)Study completedNCT00313586
What this trial is testing

Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11+12 more
National Cancer Institute (NCI) 197
Early research (Phase 1)Study completedNCT04447027
What this trial is testing

Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

Who this might be right for
Cutaneous T-Cell LymphomaMature T-cell MalignanciesPeripheral T-Cell Lymphoma+1 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Ended earlyNCT00083473
What this trial is testing

A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia, Lymphocytic, ChronicLymphoma, Small Lymphocytic
Titan Pharmaceuticals 28
Testing effectiveness (Phase 2)Study completedNCT00605657
What this trial is testing

Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)

Who this might be right for
ALPSHypersplenismLymphadenopathy
Koneti Rao 6
Testing effectiveness (Phase 2)Study completedNCT00878436
What this trial is testing

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

Who this might be right for
Prostate CancerProstatic Neoplasms
NYU Langone Health 52
Very early researchEnded earlyNCT02282917
What this trial is testing

Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma

Who this might be right for
Vestibular SchwannomaMeningiomaAcoustic Neuroma+1 more
Massachusetts Eye and Ear Infirmary 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT03600441
What this trial is testing

Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Xynomic Pharmaceuticals, Inc. 139
Testing effectiveness (Phase 2)UnknownNCT02733380
What this trial is testing

Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Henan Cancer Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00185302
What this trial is testing

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma

Who this might be right for
Melanoma
Bayer 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07261592
What this trial is testing

Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer

Who this might be right for
Bladder CancerHistone Deacetylase InhibitorEntinostat+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 29
Testing effectiveness (Phase 2)Study completedNCT01261247
What this trial is testing

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+18 more
Mayo Clinic 41
Testing effectiveness (Phase 2)Study completedNCT00918333
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+25 more
Mayo Clinic 124
Not applicableStudy completedNCT02961829
What this trial is testing

Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing Cure

Who this might be right for
Chronic InfectionHIV
Federal University of São Paulo 30
Testing effectiveness (Phase 2)Study completedNCT00843167
What this trial is testing

Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast Biopsy

Who this might be right for
Breast CancerPrecancerous Condition
OHSU Knight Cancer Institute 54
Testing effectiveness (Phase 2)Ended earlyNCT01282476
What this trial is testing

Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Massachusetts General Hospital 18
Early research (Phase 1)Study completedNCT02728492
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Who this might be right for
Non-small Cell Lung CancerEpithelial Ovarian Cancer
NewVac LLC 51
Next Page